Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ct103a cells
Idiopathic Inflammatory Myopathy
Tongji Hospital
Early P1
C
(39)
ct103a cells
Myasthenia Gravis
Tongji Hospital
Early P1
C
(39)
ct103a cells
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Tongji Hospital
Early P1
C
(39)
ct103a cells
Neuromyelitis Optica
Tongji Hospital
Early P1
C
(39)
ct103a cells
POEMS Syndrome
Tongji Hospital
Early P1
C
(39)
ct1182
B-Cell Non-Hodgkin Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Early P1
C
(39)
Cyclophosphamide
Carcinoma, Intraductal, Noninfiltrating
Laura Esserman
Early P1
C
(39)
Cyclophosphamide
CAR-T
Zhimin Zhai
Early P1
C
(39)
Cyclophosphamide
CAR-T Cell Therapy
TCRCure Biopharma Ltd.
Early P1
C
(39)
Cyclophosphamide
Effects of Immunotherapy
Shanghai Juncell Therapeutics
Early P1
C
(39)
Cyclophosphamide
Grade II Glioma
Oliver Jonas
Early P1
C
(39)
Cyclophosphamide
Grade III Glioma
Oliver Jonas
Early P1
C
(39)
Cyclophosphamide
Identified by NGS, PCR or IHC
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
Cyclophosphamide
Idiopathic Inflammatory Myopathy
Tongji Hospital
Early P1
C
(39)
Cyclophosphamide
IgAN - IgA Nephropathy
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
Cyclophosphamide
Multi-Drug Resistant Nephrotic Syndrome
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
Cyclophosphamide
Multiple Cancer
Zhejiang University
Early P1
C
(39)
Cyclophosphamide
Neoantigen
BGI, China
Early P1
C
(39)
Cyclophosphamide
Oligodendroglioma of Brain
Oliver Jonas
Early P1
C
(39)
Cyclophosphamide
POEMS Syndrome
Tongji Hospital
Early P1
C
(39)
Cyclophosphamide
Recurrent or Metastatic Solid Tumors With Positive ALPP
Haifeng Qin
Early P1
C
(39)
Cyclophosphamide
Tumor Infiltrating Lymphocytes
Shanghai Juncell Therapeutics
Early P1
C
(39)
CYCLOSPORIN A
DNA Repair Disease
Virginia G. Kaklamani
Early P1
C
(39)
Cytokine Induced Memory-Like Natural Killer Cells
Chromophobe Renal Cell Carcinoma
Dana-Farber Cancer Institute
Early P1
C
(39)
Cytokine Induced Memory-Like Natural Killer Cells
Renal Carcinoma
Dana-Farber Cancer Institute
Early P1
C
(39)
Showing 376 to 400 of 1,553 assets
Previous
Page 16 of 63
Next
